Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 9;9(6):860.
doi: 10.3390/children9060860.

Does Focal Osteolysis in a PRECICE Stryde Intramedullary Lengthening Nail Resolve after Explantation?

Affiliations

Does Focal Osteolysis in a PRECICE Stryde Intramedullary Lengthening Nail Resolve after Explantation?

Oliver C Sax et al. Children (Basel). .

Abstract

Concerns surrounding osteolysis near and around the modular junction of a stainless-steel intramedullary lengthening rod prompted a manufacturer recall from the United States market in early 2021. These actions were preceded by similar steps taken in Europe. A concomitant review of stainless-steel lengthenings at our institution demonstrated signs of adverse tissue reaction including periosteal reaction and osteolysis at the modular junction and/or male-sided locking screws. Nearly half of our patients presented with these findings on radiographic images. At the time of the previous review, only half of the nearly 60 implanted stainless-steel devices met a 6-month follow-up. At this juncture, many patients have had their devices explanted. Given the suspected adverse tissue reactions caused by a component of the internal device, we sought to examine the rate of osteolysis post-explantation following removal of a stainless-steel nail. We reviewed a consecutive series of patients who underwent implantation of a stainless-steel limb lengthening device in the femur and/or tibia at a single institution between December 2018 and December 2020. Patients were included if their device was explanted. Periosteal reaction and osteolysis was classified according to a novel and validated classification system, as analyzed by five fellowship-trained surgeons. In addition, changes observed prior to explantation were tracked post-explantation to assess for resolution. The incidence of periosteal reaction and osteolysis prior to explantation was 22/57 (39%) and 15/57 (26%), respectively. Of the 15 patients with osteolysis pre-explantation, 14 patients' implants were explanted. Of these, eight patients had available follow-up films. Two patients were identified as having partial osteolysis resolution at mean 1-year follow-up, while six patients were identified as having complete osteolysis at mean 18-months follow-up. Periosteal tissue reaction and osteolysis largely resolved following explantation in a subset of patients. These results provide further support to the claim that the stainless-steel device contributed to the changes seen. Further follow-up is warranted to examine the longer-term effects of adverse tissue reaction in this patient population.

Keywords: Stryde; intra-medullary lengthening nail; limb lengthening; osteolysis; periosteal reaction; stainless-steel device.

PubMed Disclaimer

Conflict of interest statement

No funding was received to conduct this study. J.E.H. is a clinical advisor for Bonus BioGroup and a consultant for NuVasive Specialized Orthopedics, Orthofix, OrthoPediatrics, OrthoSpin, Smith & Nephew, and WishBone Medical. The following organizations supported the institution of L.P.H. and J.E.H.: DePuy Synthes, Integra LifeSciences, NuVasive Specialized Orthopedics, Orthofix, OrthoPediatrics, Paragon 28, Pega Medical, Smith & Nephew, Stryker, Treace Medical Concepts, and WishBone Medical Inc. O.C.S., L.P.H. and K.A.K. do not have any other financial disclosures to report.

Figures

Figure 1
Figure 1
Biologic Reaction Classification System.

Similar articles

Cited by

References

    1. Gordon J.E., Davis L.E. Leg Length Discrepancy: The Natural History (And What Do We Really Know) J. Pediatr. Orthop. 2019;39:S10–S13. doi: 10.1097/BPO.0000000000001396. - DOI - PubMed
    1. Shabtai L., Specht S.C., Standard S.C., Herzenberg J.E. Internal Lengthening Device for Congenital Femoral Deficiency and Fibular Hemimelia. Clin. Orthop. Relat. Res. 2014;472:3860–3868. doi: 10.1007/s11999-014-3572-3. - DOI - PMC - PubMed
    1. Rodriguez-Ramirez A., Thacker M.M., Becerra L.C., Riddle E.C., MacKenzie W.G. Limb length discrepancy and congenital limb anomalies in fibular hemimelia. J. Pediatr. Orthop. Part B. 2010;19:436–440. doi: 10.1097/BPB.0b013e32832d5d7d. - DOI - PubMed
    1. Ilizarov G.A. The tension-stress effect on the genesis and growth of tissues. Part, I. The influence of stability of fixation and soft-tissue preservation. Clin. Orthop. Relat. Res. 1989;238:249–281. doi: 10.1097/00003086-198901000-00038. - DOI - PubMed
    1. Ilizarov G.A. The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction. Clin. Orthop. Relat. Res. 1989;239:263–285. doi: 10.1097/00003086-198902000-00029. - DOI - PubMed

LinkOut - more resources